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Nowadays, we are facing a renaissance of mitochondria in cancer biology. However, our knowledge of the basic cell biology
and on the timing and mechanisms that control the biosynthesis of mitochondrial constituents during progression through the
cell cycle of mammalian cells remain largely unknown. Herein, we document the in vivo changes on mitochondrial morphology
and dynamics that accompany cellular mitosis, and illustrate the following key points of the biogenesis of mitochondria during
progression of liver cells through the cycle: (i) the replication of nuclear and mitochondrial genomes is synchronized during
cellular proliferation, (ii) the accretion of OXPHOS proteins is asynchronously regulated during proliferation being the
synthesis of b-F1-ATPase and Hsp60 carried out also at G2/M and, (iii) the biosynthesis of cardiolipin is achieved during the S
phase, although full development of the mitochondrial membrane potential (DYm) is attained at G2/M. Furthermore, we
demonstrate using reporter constructs that the mechanism regulating the accretion of b-F1-ATPase during cellular
proliferation is controlled at the level of mRNA translation by the 39UTR of the transcript. The 39UTR-driven synthesis of
the protein at G2/M is essential for conferring to the daughter cells the original phenotype of the parental cell. Our findings
suggest that alterations on this process may promote deregulated b-F1-ATPase expression in human cancer.
Citation: Martı´nez-Diez M, Santamarı´a G, Ortega A´D, Cuezva JM (2006) Biogenesis and Dynamics of Mitochondria during the Cell Cycle: Significance
of 39UTRs. PLoS ONE 1(1): e107. doi:10.1371/journal.pone.0000107
INTRODUCTION
Cellular proliferation is an energy consuming activity that is
stringently controlled by checkpoints of the cell cycle [1].
Transition from one phase of the cycle to the next is coordinated
by the expression of specific cyclins and the sequential activation
and inactivation of cyclin-dependent protein kinases [2]. Un-
controlled proliferation is one of the hallmarks of the cancer cell
[3] that most often results from genetic alterations and/or the
inactivation of master regulators of the cell cycle [4]. Cells that
make the decision to divide must be therefore metabolically
prepared to deal with the energetic demand imposed by pro-
liferation. Alternatively, the cells can become reversibly arrested at
the G1/S boundary (restriction point) of the cell cycle. In fact,
compromising the cellular ATP levels by inhibition of mitochon-
drial oxidative phosphorylation [5,6] or by limiting the availability
of glucose [1] or by genetic alterations that compromise the
bioenergetic activity of mitochondria [7] result in G1 arrest of the
cells. The G1/S arrest is triggered by a metabolic stress checkpoint
of the cycle that is controlled by the activation of AMP-activated
protein kinase (AMPK) [1] which is a metabolic sensor of the
energy charge in higher eukaryotic cells [8]. The activation of
AMPK promotes the phosphorylation of p53 at Ser15 [1],
a modification that prevents its degradation and results in the
cellular accumulation of p53 and cell-cycle arrest. Various studies
have shown that entry of cells into the G1 phase of the cycle is
associated with a burst of mitochondrial activity [5,9]. However, it
appears that progression through the cycle is supported by non-
respiratory modes of energy generation [10–12]. In fact, very
recent findings in cells of mammals indicate that cyclin D1 which
is involved in the phosphorylation and inactivation of the
retinoblastoma protein, marking the entry of cells into the S
phase of the cycle, inhibits mitochondrial function [13] and
represses the activity of NRF-1 [14], a nuclear factor that masters
the transcriptional expression of nuclear-encoded mitochondrial
genes [15].
Mitochondria participate in a large number of essential cellular
functions. Genetic or epigenetic alterations that impact on
mitochondrial functions are thus involved in the development of
human pathologies with quite different phenotypic presentations
[16], that include physiological ageing [17]. The provision of
metabolic energy by oxidative phosphorylation (OXPHOS) is the
best characterized function of mitochondria. In the process of
oxidative phosphorylation, ATP is synthesized from ADP and Pi
by the mitochondrial H+-ATP synthase [18], a rotatory engine
complex of the inner mitochondrial membrane that utilizes as
driving force the proton electrochemical gradient generated by the
respiratory chain [19]. The catalytic activity of the H+-ATP
synthase is located in the b-subunit of the water-soluble F1 portion
(b-F1-ATPase) of the complex which is encoded in the nuclear
genome [20]. The regulation of the expression of b-F1-ATPase is
exerted at the level of translation [21–25]. The b-F1-ATPase
mRNA (b-mRNA) further provides an example of a mitochondria-
localized mRNA in both mammalian [26–29] and lower
eukaryotic cells [30,31] whose efficient translation depends on
the 39 non-translated region (39UTR) of the mRNA [24,30,32,33].
Translation masking of b-mRNA occurred both in the fetal liver
[24] and in hepatomas [25], compromising the biogenesis of
mitochondria during development and in oncogenesis [34,35].
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The biogenesis of mitochondria is a complex cellular event
requiring the concerted expression of two physically separated
genomes [15,35–37]. However, and despite the relevant role
played by mitochondria in the onset and progression of human
pathology, our knowledge of the timing of the biosynthesis of
the different mitochondrial constituents and on the mechanisms
that regulate their biosynthesis during cellular proliferation are
scarce or remain largely unknown. Even less explored are the
dynamics and changes in mitochondrial morphology during
mitosis, a process that is likely to impact on the development of
mitochondrial function and on the segregation of the organelles
during progression through the cell cycle. Because of the
renaissance of mitochondrial studies in cancer biology [38–41],
in this work we have studied the timing of the biosynthesis of
different mitochondrial constituents during progression through
the cell cycle and the changes on mitochondrial morphology and
dynamics that accompany cellular mitosis. Mechanistically, we
document the relevance that the 39UTR (39 non-translated region)
of b-mRNA has for the synthesis of the protein at G2/M and
illustrate the role that a regulatory mRNA sequence has for the
appropriate biogenesis of mitochondria in the daughter cells with
the same bioenergetic phenotype than that of the parental cell.
This discovery highlights a previously unappreciated relationship
between the control of translation at G2/M and the biogenesis of
mammalian mitochondria that is likely to influence the cancer
field.
RESULTS
Biosynthesis of mitochondrial constituents during
the cell cycle
Subconfluent cultures of liver C9 cells were synchronized by
metabolic arrest at the beginning of the S phase (see Fig. S1 in
Supporting Information). The arrest of the cell cycle promoted
a significant increase in the proportion of cells in G0/G1
concurrent with a reduction of the proportion of cells in S and
G2/M (Fig. S1). At various times (0–10 h) after release from the
metabolic block cells were recovered and the relative cellular
content of mtDNA (Fig. 1A) and mitochondrial proteins (Fig. 1B)
determined. It should be noted that at 4h after release from the
arrest the percentage of cells in the different phases of the cycle
were basically the same (Fig. S1) being the percentage of cells in
G2/M 2-fold and 5-fold higher than that of non-arrested and
arrested cells, respectively (Fig. S1). The relative cellular content
of mitochondrial DNA (mtDNA), as determined by the ratio of
the mitochondrial 12S rRNA gene to the nuclear b-F1-ATPase
gene did not show significant deviations from the initially
observed value (dotted line in Fig. 1A), suggesting that synthesis
of nuclear and mitochondrial DNA is coordinated during cell
cycle progression. Contrary to this finding, we observed that the
relative cellular content of the catalytic subunit of the
mitochondrial H+-ATP synthase (b-F1-ATPase/tubulin ratio)
and of the structural heat shock protein 60 (hsp60) (hsp60/
Figure 1. Changes in mitochondrial constituents during the cell cycle. Synchronized C9 cells (A–C) were recovered at the indicated time intervals
and the relative cellular content of mtDNA (A) and proteins (B–C) determined. No significant changes in the cellular abundance of the mitochondrial
12S gene are observed. However, the cellular content of b-F1-ATPase, Hsp60 and cyclin B1 showed a significant increase at 4 h after release from the
metabolic arrest. Representative experiments are shown (A–C). * and **, P,0.05 and ,0.005 when compared with 0–2 h. D, The fluorescence
intensity of the NAO probe was used to determine changes on mitochondrial mass during the cell cycle of non-synchronized C9 cells. The results
shown are the means6SEM of three experiments. *, P,0.05 when compared with cells in G0/G1.
doi:10.1371/journal.pone.0000107.g001
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tubulin ratio) showed a significant increase at 4 h (Fig. 1B).
Analysis of the cellular expression level of cyclin B1 (cyclin B1/
tubulin ratio), that is known to peak at mitosis, also revealed
a significant increase 4h after initiation of the cell cycle (Fig. 1C),
suggesting that mitosis is the cell-cycle phase where the
preferential synthesis of these mitochondrial proteins is taking
place.
To assess the build up of the inner mitochondrial membrane
during progression through the cycle changes in the amount of
cardiolipin were determined by flow cytometry using the
fluorescent NAO probe (Fig. 1D). The mean fluorescence intensity
of NAO-stained cells increased significantly in S phase when
compared to cells in G0/G1 (Fig. 1D). No further significant
changes were observed in NAO fluorescence in the cells at G2/M
(Fig. 1D), indicating that the biosynthesis of the phospholipid of
the inner membrane is completed in S phase.
Asynchronous accretion of mitochondrial proteins
during the cycle
The cellular content of various mitochondrial proteins was further
analyzed by flow cytometry in non-synchronized C9 cells (see Fig.
S2 in Supplementary Information for controls of cytometry and
representative experiments for each of the protein markers
assayed). We observed that whereas the nuclear (COXIV) and
mitochondrial (COXI) encoded subunits of respiratory complex
IV (cytochrome c oxidase subunits IV and I, respectively)
accumulated almost entirely during S phase (Figs. 2A and S2),
the accumulation of b-F1-ATPase and hsp60 occurred throughout
the cycle with a significant increase at G2/M when compared to
cells in S phase (Figs. 2A and S2). The preferential build up of b-
F1-ATPase and hsp60 at G2/M, and parallel accretion of these
two proteins during the cycle, was further confirmed by western
blotting of cells sorted according to their DNA content as revealed
by the sharp increase in b-F1/COXIV ratio at G2/M (Fig. 2B)
and the lack of significant deviations in b-F1/hsp60 ratio (Fig. 2B),
respectively.
The preferential synthesis of b-F1-ATPase at G2/M
occurs in the absence of changes in mRNA
abundance
To explore the possibility that b-F1-ATPase mRNA abundance
could be regulated during the cycle gearing the synthesis and
accumulation of the protein we determined the relative cellular
content of b-mRNA in synchronized C9 cells at various times
after release from the metabolic block. The expression of b-
mRNA was determined (Fig. 2C) in the same cultures where
the protein expression was assessed (Fig. 1B). No significant
changes in the relative cellular content of b-mRNA (as assessed
by any of the following ratios: b-mRNA/18S rRNA, b-mRNA/
ATPase 6–8 mRNA and b-mRNA/12S rRNA) was observed
(Fig. 2C). Furthermore, we also determined the relative
expression of b-mRNA in cells sorted according to their DNA
content and found the lack of significant changes in the
normalized expression of b-mRNA in the different phases of the
cycle (1.0060.10, 0.8360.12 and 1.2160.10 for cells in G0/
G1, S and G2/M, respectively). Overall, the results suggest that
the accumulation of the protein during cellular proliferation
(Figs. 1B, 2A and 2B) is mainly controlled at the level of
translation although it cannot be excluded that mechanisms that
control the subcellular localization of the mRNA [26–29,31]
might as well contribute to the observed accretion of the protein
during the cell cycle.
Functional differentiation of mitochondria during
the cell cycle
To assess the stage of functional differentiation of mitochondria
during the cell cycle, changes in the mitochondrial membrane
potential (DYm) were determined by FACS analysis using the
TMRM+ probe. The mean fluorescence intensity of TMRM-
stained cells increased significantly in S phase when compared to
cells in G0/G1 (Fig. 2D). However, and contrary to the results
observed with the NAO probe (Fig. 1D), the mean fluorescence
intensity of TMRM-stained cells further showed a significant
increase at G2/M (Fig. 2D), indicating that full development of
DYm is attained only after G2/M-dependent events have been
completed.
The presequence of b-F1-ATPase precursor targets
gfp to the mitochondria
To test the possibility that changes in the translation efficiency of
b-mRNA could trigger the accumulation of the protein during
progression through the cycle we studied the expression of a gfp
reporter derived from a construct that contained the 39UTR
regulatory element of b-mRNA translation [24,32]. However, and
because of the cytotoxic effect of gfp when it is expressed in the
cytoplasm [33] the development of stable cellular clones by this
approach resulted unsuccessful. Therefore, we decided to target
gfp to the mitochondria by inframe fusion at the N-terminal of gfp
the presequence of the rat liver b-F1-ATPase precursor protein.
This strategy allowed the generation of stable clones of
mammalian cells that express gfp in their mitochondria (Fig. 3A)
as assessed by confocal (Fig. 3B) and immunoelectron (Fig. 3C)
microscopy. Interestingly, it was not possible to detect significant
amounts of the pb-gfp chimeric protein in cellular extracts of the
C9-pbGFP39b clone (see Fig. 3D, lane 1), suggesting a fast and
efficient in vivo import of the chimeric protein in this cell line.
However, when transfecting the same construct into BHK cells we
detected the pb-gfp precursor (Fig. 3D, lane 2). Moreover,
treatment of these cells with carbonyl cyanide p-trifluoro-
methoxy-phenylhydrazone (FCCP), a drug that collapses DYm
and prevents the import of precursor proteins into the organelle,
revealed the rapid accumulation of pb-gfp in BHK cellular
extracts (Fig. 3D, lanes 3). Upon removal of FCCP from the
culture medium, the pb-gfp precursor was rapidly imported into
mitochondria and processed to mature gfp (Fig. 3D, lane 4). These
results illustrate cell-type specific differences in the import pathway
of proteins into mitochondria in cells of mammals.
Gfp derived from the C9-pbGFP39b clone is
preferentially synthesized at G2/M
Analysis of the relative cellular expression level of gfp in non-
synchronized C9-pbGFP39b cells, as assessed by the gfp/tubulin
ratio, revealed a constant expression level of the protein as cells
proliferate (data not shown). In contrast, the same analysis in
synchronized C9-pbGFP39b cells revealed a significant and
preferential accumulation of gfp at 4 h after release from the
metabolic block (Fig. 4A), indicating that the synthesis of gfp
driven from the construct that contains the presequence and
39UTR of b-mRNA coincides with that of the endogenous b-F1-
ATPase (Fig. 1B) and is preferential at the time of mitosis (Fig. 1C).
Determination of the relative cellular content of the chimeric gfp-
mRNA in synchronized C9-pbGFP39b cells revealed a constant
expression level of this mRNA during the cycle (Fig. 4B),
suggesting that the accumulation of gfp at G2/M is controlled at
the level of translation.
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The 39UTR of b-mRNA controls the accumulation of
the protein at G2/M
In order to define which of the two b-mRNA elements
(presequence and 39UTR) is responsible for the preferential
synthesis of the protein at G2/M we generated additional stable
clones of the C9 cell line in which the 39UTR of b-mRNA was
replaced by the 39UTR of mitochondrial transcription factor A
(Tfam). The 39UTR of Tfam lacks translation enhancing activity
when compared to the activity of the 39UTRs of other OXPHOS
transcripts [33]. Consistent with this, we observed that the
expression of gfp in C9-pbGFP39Tfam cells was much less than
Figure 2. Asynchronous accumulation of mitochondrial proteins and development DYm during the cell cycle. A, Determination of the expression
level of b-F1-ATPase (b-F1), Hsp60 and cytochrome c oxidase subunits I (COXI) and IV (COXIV) in C9 cells in the different phases of cell cycle by flow
cytometry. Open bars, G0/G1; grey bars, S and black bars, G2/M. The results shown are the means6SEM of four experiments. * and #, P, 0.05 when
compared with cells in G0/G1 and S, respectively. B, C9 cells were sorted by flow cytometry according to their DNA content and the protein extracts
fractionated and blotted with the indicated antibodies. The two bands shown under each condition are from two independent experiments. The
results shown in the graph are the means6SEM of three experiments. *, P,0.05 when compared with cells in S phase. C, Synchronized C9 cells were
recovered at the indicated time intervals and the relative cellular content of b-F1-ATPase mRNA determined by Northern-blot analysis. The
mitochondrial encoded ATPase 6–8 mRNA and 12S rRNA and the nuclear encoded 18S rRNA were also determined. The results shown are the
means6SEM of four experiments. D, FACS determination of the mitochondrial membrane potential (DYm) in C9 cells in the different phases of the
cell cycle. The results shown are the means6SEM of three experiments. *, P,0.05 when compared with cells in G0/G1.
doi:10.1371/journal.pone.0000107.g002
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that in C9-pbGFP39b cells (Fig. 4C). However, the C9-
pbGFP39Tfam clone also efficiently targeted gfp to mitochondria
in C9 cells showing no cellular accumulation of the pb-gfp
chimera (Fig. 4C, and data not shown).
To assess the role of the 39UTRs in the synthesis of gfp during
the cycle we determined the relative changes in gfp fluorescence of
the C9-pbGFP39b and C9-pbGFP39Tfam cells (Fig. 4D). In both
clones the mean fluorescence intensity of the cells increased as they
progress through the cycle (Fig. 4D). However, the relative
increase in cellular fluorescence observed in C9-pbGFP39b cells
exceeded by far that determined in C9-pbGFP39Tfam cells both
in S phase and at G2/M (Fig. 4D). In fact, C9-pbGFP39Tfam cells
did not synthesize the amount of gfp that is required for
appropriate cellular division into daughter cells with the same
maternal gfp phenotype (Fig. 4D). Therefore, the results support
that the 39UTR of b-mRNA is the core controlling element
required for the biosynthesis of b-F1-ATPase and for the appro-
priate biogenesis of mitochondria during cellular proliferation.
Dynamics of the mitochondrial network during
mitosis
The mitochondrial network is a dynamic structure that is
permanently subjected to remodeling by changes in the morphol-
ogy and subcellular localization of the organelles [42]. Organelle
changes are relevant for cellular metabolism [43], the execution of
apoptosis [6,44], Ca2+ signaling [45], viral infection [46] and
impact on various human pathologies [47]. However, the timing
of the morphological changes experienced by mitochondria during
mitosis in cells of mammals is unknown. In this regard, the
generation of mammalian cell lines with green mitochondria
allowed us to visualize in vivo the morphology and dynamics of
mitochondria during mitosis (see supporting video S1 and Fig. S3)
as well as within the context of elements of the cytoskeleton (Fig. 5).
The analysis of synchronized C9-pbGFP39b cells at 4h after
release from the metabolic block confirmed that a large proportion
of the cells (.40%) were undergoing mitosis (Fig. 5). The
morphology of mitochondria in cells in interphase is that of
threads, or of a tubular network, that it is intertwined with the
tubulin and actin cytoskeleton. Mitochondria in cells in interphase
are preferentially clustered around the nucleus, although some
mitochondria are also located in the cell periphery (Fig. 5). By the
time cells enter mitosis the mitochondrial tubular network is
disorganized and fission of the thread-like organelles had occurred
with some of the mitochondria already appearing as punctuate
organelles (especially in metaphase) (Fig. 5). During the early
stages of mitosis mitochondria are excluded from the cellular space
where the mitotic spindle is being assembled (prophase) as well as
from the equator of the spindle where the chromosomes line up
(metaphase) (Fig. 5). During anaphase mitochondria still display
a punctuate morphology appearing evenly distributed in the cell
periphery (Fig. 5). By the time of late-anaphase or early-telophase
Figure 3. The presequence of b-F1-ATPase precursor targets gfp to mitochondria. The expression of gfp in C9 (A,B) and BHK (C) cells was assessed
by fluorescence (A), immunofluorescence (B) and immunoelectron (C) microscopy. A, Illustrates by phase contrast (upper panel) and
immunofluorescence (lower panel) the same low magnification field of C9-pbGFP39b cells. B, C9-pbGFP39b cells analyzed by immunofluorescence
microscopy using anti-b-F1-ATPase antibody at 636 magnification. Upper panel, green gfp fluorescence; middle panel, red b-F1-ATPase
immunostaining; lower panel, yellow merged image. C, Specific immunogold labeling (10 nm gold) of BHK mitochondria (m). Note the lack of gold
labeling of other structures in the cytoplasm or in the nucleus (n) of the cell. D, Western blots of C9 (lane 1) and BHK cells (lanes 2–4) transfected with
the pbGFP39b construct. Fractionated proteins from the cellular extracts were probed with anti-gfp and anti-tubulin, the later as loading control. The
migration of the pb-gfp chimera is also indicated. In lane 3, BHK cells have been previously treated with FCCP (4 mM) plus oligomycin (2 mM) for
1 hour. Note the accumulation of pb-gfp. In lane 4, BHK cells treated as in lane 3 were washed for 40 minutes before fractionation. Note the
processing of pb-gfp to mature gfp.
doi:10.1371/journal.pone.0000107.g003
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some punctuate mitochondria initiate the repopulation of the
spindle equator after the segregation of the daughter chromosomes
had occurred (Fig. 5). In late-telophase, just before cytokinesis,
mitochondria initiate their change in morphology also appearing
as thread-like structures (Fig. 5). Overall, the cellular distribution
of mitochondria during mitosis appears not to be co-distributed
with the majority of the tubulin and b-actin cytoskeleton (Fig. 5).
Of note is the enrichment of b-actin in the cell cortex (the red layer
beneath the plasma membrane) during mitosis (Figs. 5g, 5h) that
governs the formation of filopodia (the thin red stiff protrusions on
Fig. 5g) responsible for promoting the dramatic changes in cell
shape during mitosis (see phase contrast images on supporting
video S1 and Fig. S3).
DISCUSSION
The timing of the biosynthesis of mtDNA in cells of mammals
during progression through the cell-cycle is nowadays a matter of
debate. In this regard, the replication of mtDNA has been
described to proceed continuously during the cycle [48,49] or to
occur at a specific stage of the cycle (late S-G2/M) after most
nDNA synthesis has been completed [50,51]. The lack of
significant changes on the cellular representation of mtDNA in
liver cells during cellular proliferation suggests that mtDNA and
nDNA synthesis is coordinated and supports a concerted trans-
activation of the replication of both genomes [52]. The synchron-
ous replication of both genomes is not incompatible with localized
Figure 4. The 39UTR of b-F1-ATPase mRNA controls the accumulation of the protein at G2/M. Synchronized C9-pbGFP39b cells (A,B) were
recovered at the indicated time intervals and the relative cellular content of gfp protein (gfp/tubulin ratio) (A) and gfp mRNA (gfp/12S ratio) (B)
determined. The results shown are the means6SEM of three (A) and four (B) experiments. A significant accumulation of gfp protein was observed at
four h after release from the metabolic arrest. *, P,0.0005 when compared with 0–2 h. No significant changes in the cellular abundance of gfp mRNA
was observed during cellular proliferation. C, The upper panel shows a merged image of the immunofluorescence microscopy of C9-pbGFPTfam cells
that illustrates the co-localization of gfp and b-F1-ATPase, thus revealing the efficient targeting of gfp to mitochondria in this cellular clone (for other
details see Fig. 3B). The lower panel shows the western blots of fractionated proteins from cellular extracts of parental C9 (C9), C9-pbGFP39b (39b) and
C9-pbGFPTfam (Tfam) cells simultaneously probed with anti-gfp and anti-tubulin. D, Analysis of gfp expression in C9-pbGFP39b (closed bars) and C9-
pbGFP39Tfam (open bars) cells in the different phases of the cell cycle by flow cytometry. The results shown are the means6SEM of four experiments.
*, P,0.05 when compared with C9-pbGFP39b cells and #, P,0.05 when compared S with G2/M in C9-pbGFP39b cells.
doi:10.1371/journal.pone.0000107.g004
Biogenesis of Mitochondria
PLoS ONE | www.plosone.org 6 December 2006 | Issue 1 | e107
Figure 5. Morphological changes in the cellular mitochondrial network during mitosis. Synchronized mitochondria-tagged C9-pbGFP39b cells
were analyzed by immunofluorescence microscopy at four hours after release from the metabolic block. Typical morphologies of cells in interphase
(a,f), prophase (b), metaphase (c,g), anaphase (d) and telophase (e,h) are shown at 606magnification. The red fluorescence identifies the cytoskeletal
proteins a-tubulin (a–e) and b-actin (f–h). The green fluorescence identifies mitochondria. The blue fluorescence reveals the stained nuclear DNA with
the To-Pro probe.
doi:10.1371/journal.pone.0000107.g005
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[53] or delocalized synthesis of mtDNA [49] which might
represent events of mtDNA turnover and/or repair of the
nucleoid.
Consistent with the prominent role played by cardiolipin in
translation of mitochondrial proteins and on the biogenesis of
OXPHOS complexes ([54–56] and references therein) we
observed that synthesis of the mitochondrial encoded COXI
protein is fully accounted in S phase concurrently with the
synthesis of cardiolipin and of the nuclear-encoded counterpart
subunit COXIV. However, we observed that a fully developed
DYm is not attained until G2/M (Fig. 2D) [57]. The assembly and
oligomerization of the H+-ATP synthase has been shown to play
a critical role in the folding of the inner membrane into cristae
morphology [58–60]. Moreover, in yeast cells the activity of
the ATPase has been shown to be strictly required for the
maintenance of mitochondrial integrity and mtDNA [61]. It is
thus reasonable to suggest that the synthesis of b-F1-ATPase, and
perhaps of other nuclear-encoded OXPHOS components whose
synthesis is driven at G2/M, could rate-limit the development of
a functional organelle during cellular proliferation.
The regulation of the expression of nuclear and mitochondrial
genes during the cell cycle has been described at both the level of
transcription [15,62,63] and by changes in the half-life of the
mRNAs [15,63–65]. However, the buildup of b-F1-ATPase
during cellular proliferation occurs in the absence of changes in
the cellular abundance of its mRNA consistent with the stringent
translational control described for this transcript [21–25].
Moreover, the expression of a reporter driven from a chimeric
mRNA containing the regulatory 39UTR of b-mRNA recapitu-
lated the same pattern and mechanism of expression of the
endogenous protein during cellular proliferation, providing the
first indication that translation at G2/M is also required for
the synthesis of an essential component of mitochondria, and
supporting that cell-cycle regulated changes in the translational
efficiency of some OXPHOS transcripts play a prominent role in
the biogenesis of mitochondria.
It is well established that cap-dependent translation is inhibited
at mitosis as a result of multiple events that lead to the disruption
of the eIF4F complex [66]. At this stage of the cycle cap-
independent translation drives the synthesis of relevant cellular
proteins from a set of internal ribosome entry site (IRES)-
containing mRNAs [67–69]. Consistent with the synthesis of b-F1-
ATPase at G2/M, the translation of b-mRNA has been shown to
have a lesser dependence on eIF4E than other cellular mRNAs
[32]. Moreover, the 39UTR of b-mRNA acts as a translation
enhancing sequence [24,33] that displays IRES-like activity in
dicistronics constructs [32]. Therefore, an important conclusion
resulting from this work is that the 39UTR-located IRES of
b-mRNA is the target of cell cycle-dependent translational
regulation.
The mammalian b-mRNA was the first nuclear-encoded
transcript of the mitochondria shown to be localized and attached
to the outer mitochondrial membrane [26–28]. Localization/
translation of the mRNA requires two cis-acting elements
respectively located in the ORF and in the 39UTR of the mRNA
[29]. The cis-acting element located on the ORF exerts a negative
control on mRNA translation ([24] and Santamaria and Cuezva,
unpublished observation). For efficient translation of b-mRNA it is
required the IRES-like translation enhancing activity of the
39UTR [24,32]. Such translation enhancing activity of the
39UTR of b-mRNA has also been observed in the 39UTRs of
other transcripts involved in the OXPHOS system of mammals
[33] and yeast [31] cells. In fact, ablation of the 39UTR in the
yeast b-F1-ATPase gene resulted in cells with respiratory
deficiency [30] although such phenotype has been attributed to
a defective import of b-F1-ATPase rather than to the activity of
the 39UTR on translation. Consistent with this essential role of the
39UTR of the transcript in the synthesis of b-F1-ATPase our
efforts to develop a mouse with a genetic deletion on the 39UTR of
the b-F1-ATPase gene by homologous recombination (IngenKO,
Australia) have resulted unsuccessful (data not shown).
The trans-acting factors of the 39UTR of b-mRNA that have
been shown to control the translation of the mRNA during liver
development [24] and in oncogenesis [25] have poly A binding
activity [70]. Unfortunately, the molecular nature of these RNA
binding proteins still remains elusive. However, we have recently
observed that both a reduced environment and a low ATP/ADP
ratio favor the binding of these proteins to its target [70] what
results in translation masking of the mRNA [22,24,25]. A burst of
mitochondrial respiration has been noted upon serum stimulation
of quiescent mammalian cells [9]. However, progression through
the cell cycle is stringently controlled by the regulation of the
metabolic pathways involved in energy generation [10,11,71].
Essentially, the ‘‘metabolic cycle’’ during cellular proliferation
alternates between a first oxidative phase that is characterized by the
biosynthesis of many cellular components (G1 phase) and is
supported by the energy derived from mitochondrial activity
followed by a reductive phase were the replication of DNA and the
biosynthesis of mitochondria (S/G2/M phases) is supported by
non-respiratory modes of energy generation [10,11,71]. The
operation of the metabolic cycle in cells of mammals have received
recent support after the observation that cyclin D1 represses
mitochondrial function in vivo [13,14]. We therefore suggest that
control of b-mRNA translation in the reductive phase that prevails
at G2/M should have additional players that control the
interactions of trans-acting factors of the 39UTR with its target
to allow the translation of the mRNA in such unfavorable
metabolic situation. Since the expression of b-F1-ATPase is
down-regulated in most human cancers [38,72] contributing to
tumor progression [38,39,73] we believe that such regulators are
responsible for promoting deregulated b-F1-ATPase expression in
the cancer cell.
Finally, we presume that the rapid changes in mitochondrial
morphology and dynamics that accompany mitosis might be of
relevance for the appropriate segregation of the organelles and
mtDNA into daughter cells during proliferation. We showed that
fission of mitochondria is an early event of mitosis that might be
triggered in response to the signaling cascades that accompany
progression through the cell cycle. In fact, similar rapid fission
events on the mitochondrial network are observed after treatment
of the cells with an inhibitor of protein kinases [6]. Fission of the
organelle is likely to be triggered by proteasomal degradation of
mitofusins [74]. Functionally, fission of mitochondria assures
a stochastic distribution of the organelles within the two daughter
cells by a process that might be actively controlled and mediated
by microtubules [75]. However, it has been reported that after
mitochondrial fission 25–40% of the organelles lack mtDNA [76].
This situation could contribute to the asymmetric segregation of
mtDNA into daughter cells explaining certain mtDNA depletion
syndromes [47]. However, the fusion of mitochondria in late
telophase, just before citokinesis, a process that is controlled by
mitofusins and the development of DYm [77], is likely to
ameliorate the possible unequal distribution of mtDNA during
cellular proliferation.
Overall, we have provided a comprehensive picture of the
biogenesis of mammalian mitochondria during cellular prolifera-
tion and illustrated the relevance of translational control by the
39UTR of an OXPHOS mRNA for the appropriate biogenesis of
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the organelle during cell cycle progression. We hope that these
findings will contribute to the understanding of certain human
pathologies that impinge on organelle malfunction as a result of
deregulated cellular proliferation.
MATERIALS AND METHODS
Cell cultures
Rat liver clone 9 (C9) and BHK (Baby Hamster Kidney) cells
were grown at 37uC in DMEM with 10% fetal calf serum (FCS)
[6]. Liver C9 cells were arrested at the beginning of S phase by
a double thymidine block. In brief, subconfluent cultures were
treated with 2 mM thymidine for 10 h. Afterwards, the cells
were washed twice with DMEM and then grown for 6 hours in
drug-free medium supplemented with 24 mM 29-deoxycytidine.
Cells were arrested for a second time with 2 mM thymidine
for 10 h and after grown in DMEM containing 24 mM
29-deoxycytidine.
DNA constructs and cellular cloning
The pJMI-b-F1 plasmid [24], that contains the full-length rat liver
b-F1-ATPase cDNA, was digested with Ban I for obtaining the
fragment encoding the mitochondrial targeting sequence of b-F1-
ATPase. The resulting cDNA fragment was cloned in the Eco 47
III site of plasmids CDL-GFP-b-39UTR and CDL-GFP-Tfam-
39UTR [33], that express chimaeric RNAs of GFP with the 39-
UTRs of b-F1-ATPase and Tfam mRNAs, respectively. The
sequence of the resulting plasmids pb-GFP-b-39UTR and pb-
GFP-Tfam-39UTR, both expressing the same fusion protein
between the mitochondrial targeting sequence of b-F1-ATPase
and GFP (pb-gfp), was verified by automated DNA sequencing.
Cells were transfected at 60–80% confluence using 1 ml of
FUGENE 6 (Boehringer Mannheim, Germany) and 0.5 mg of
DNA/16105 cells in 1 ml of culture medium [33]. Positive cells
expressing gfp in their mitochondria were selected by incubation
with 40 mg/ml of geneticin (G-418) (GIBCO) and cloning
cylinders (868 mm).
Nucleic acids hybridizations
DNA and RNA were extracted from C9 cells and processed for
hybridization of nucleic acids onto nylon membranes (GeneSc-
reen) [33]. Membranes were incubated with [32P]dCTP-labeled
DNA probes [25], exposed to X-ray films and analyzed by
densitometry. Cytoplasmic RNA of sorted cells was extracted with
RNeasy mini kit (Qiagen) following the manufacturer instructions.
RNA quality was assessed previously to retro-transcription (RT)
with High-Capacity cDNA Archive Kit (Applied Biosystems).
qPCR was carried out on three different RT reactions.
Oligonucleotides used for qPCR amplification were: 59-gcaat-
tattccccatgaacg-39 and 59-gggacttaatcaacgcaagc-39 for 18S rRNA;
59-ggtatggaatcctgtggcatccatgaaa-39 and 59-gtgctaaaacgcagctcag-
taacagtcc-39 for b-Actin mRNA and 59-aaagctggtgcccctgaag-39
and 59-ggagatggtcatagtcacctgct-39 for b-F1-ATPase mRNA. For
qPCR, 5 ng of cDNA (template) and 0.5 mM of each primer
together with Power Sybr Green PCR Master Mix (Applied
Biosystems) were used following the protocol: 109695uC followed
by 20–40 cycles of denaturation (150695uC) and annealing-
elongation (19660uC) with fluorescence acquisition at 60uC. A
melting curve (150695uC, 150660uC and 150695uC) with
fluorescence acquisition at 60u to 95uC was included in each
qPCR. The amplification efficiency of each primer was empirically
determined and applied to the relative quantification of the data
using qbase software (http://medgen.ugent.be/qbase/).
Western-blots
Cells were recovered from the plates by trypsin treatment, washed
twice with PBS and boiled in loading buffer. Cellular proteins were
fractionated on SDS-12% PAGE and then transferred onto PVDF
membranes for immunoblot analysis [25]. The primary monoclonal
antibodies used were: anti-GFP (Clontech, 1:1000), anti-a-tubulin
(Sigma, 1:1000), anti-hsp60 (Stressgene SPA807, 1:3000), anti-
COXIV (Molecular Probes, 1:100) and anti-cyclin B1 (Santa Cruz
Biotechnology, 1:100). The primary polyclonal antibody used was
anti-b-F1-ATPase (1:30000) [38]. Peroxidase-conjugated anti-mouse
or anti-rabbit IgGs (Nordic Immunology, 1:3000) were used as
secondary antibodies. The blots were developed using the ECLH
reagent (Amersham Pharmacia Biotech, Little Chalfont, U.K.).
Mitochondrial membrane potential (DYm) and
mitochondrial mass
The fluorescent TMRM+ and NAO probes (Molecular Probes,
Eugene, Oregon) were used to analyze DYm and mitochondrial
mass by flow cytometry, respectively [6]. The cellular fluorescence
intensity was measured using a FACScan flow cytometer (Becton-
Dickinson, San Jose´, CA.). For each analysis 10,000 events were
recorded.
Flow Cytometry Analysis
For the determination of the cellular content of mitochondrial
proteins in the different phases of the cell cycle, ,16106 C9 cells
were washed in ice-cold staining buffer (1% BSA, 1% FCS and
0.01% sodium azide in PBS) and further incubated with primary
monoclonal antibodies against b-F1-ATPase (Molecular Probes,
0.02 mg/ml), Hsp60 (Stressgene, 0.01 mg/ml), COXI and COXIV
(Molecular Probes, both at 0.04 mg/ml) in staining buffer
supplemented with 0.3% saponin. The cells were then washed in
ice-cold PBS-saponin buffer and incubated in the dark for 20 min
with goat anti-mouse IgG conjugated to Alexa 488. Finally, the
cells were resuspended in PBS-staining buffer containing 5 mg/ml
of propidium iodide (Sigma) and 100 mg/ml RNase A and further
incubated for 20 min at 37uC.
For the determination of the cellular content of the expressed
gfp in C9-pbGFP39b and C9-pbGFP39Tfam cells, ,16106 cells
were fixed with 0.25% paraformaldehyde in PBS for 5 min. After,
the cells were resuspended in 70% ice-cold ethanol, collected by
centrifugation and finally incubated for 30 min at 37uC in PBS
containing 100 mg/ml of RNase A and 20 mg/ml of propidium
iodide. The mean fluorescence intensity of the cells was de-
termined after excitation at a wavelength of 488nm on a FACScan.
For computer analysis only the signals from single cells were
considered (10,000 cells/assay). Data analysis was carried out
using Flow Jo 6.4.1 for Mac.
For the separation of the cells in G0/G1, S and G2/M phases of
the cycle, cells were stained for 10 minutes with 5 mg/ml of Hoescht
33342 added to the culture media. Cells (,56106 cells/ml) were
resuspended in PBS containing 5 mM EDTA, 25 mM HEPES
pH 7.0 and the cellular aggregates removed by filtration through
70 mm pore filters. Cells were sorted in a FACSCVantage SE (BD
Biosciences, Erembodegen, Belgium) according to their DNA
content and collected in 0.5 ml of FCS. The purity of each fraction
was assessed in an aliquot of propidium iodide stained cells.
Immunofluorescence/confocal microscopy
Fluorescence and indirect immunofluorescence microscopy was
performed on mitochondria-tagged gfp C9 cells as recently
described in detail [6]. The primary antibodies used were mouse
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monoclonal anti-a-tubulin and anti-b-actin (both from Sigma,
1:200). The primary polyclonal antibody used was anti-b-F1-
ATPase (1:1000) [38]. After three PBS rinses, the cells were
incubated for 1 h in the dark with goat anti-mouse or goat anti-
rabbit IgGs conjugated to Alexa 594 (Molecular Probes) at 1:1000
dilution. The nuclei were stained with ToPro3 (Molecular Probes).
Cellular fluorescence was analyzed by confocal microscopy using
a Biorad Radiance 2000 Zeiss Axiovert S100TV using the following
excitation/emission wave lengths: green (498/516 nm), red (590/
617 nm) and blue (642/661 nm). The fluorescence emission of gfp
was also analyzed in a Leica DMIRB fluorescence microscope
equipped with a gfp excitation filter (Leica, BP 470/40).
Immunocytochemical localization of gfp by electron
microscopy
Cells were fixed in freshly prepared 4% paraformaldehyde in
0.1 M So¨rensen phosphate buffer, pH 7.2, for 2 h at 4uC. The
free-aldehyde groups were quenched with 50 mM ammonium
chloride in PBS for 60 min at 4uC. Samples were dehydrated in
acetone and finally processed for embedding in Lowicryl K4M
(Polysciences Europe, Eppelheim, Germany) [27]. Ultrathin
sections were collected in collodion/carbon-coated nickel grids.
Grids were incubated for 5 min with PBS containing 1% BSA and
then incubated with anti-gfp (1:100). After three washes with PBS,
grids were incubated for 45 min with goat anti-rabbit IgGs
conjugated with 10 nm colloidal gold (British BioCell, Cardiff,
UK). The grids were washed twice in PBS and distilled water, and
air-dried. Counterstaining was performed with 2% aqueous uranyl
acetate (6 min) and Reynolds lead citrate (45 s). Observation was
performed in a Jeol 1010 electron microscope under 80 kV
accelerating voltage.
Online supplementary material
For live imaging presented in the supplementary video, mito-
chondria-tagged gfp C9 cells were grown on glass plates and live
images were taken in a Cell Observer Zeiss equipment using
a Zeiss Axiovert 200 inverted microscope equipped with a Cool-
snap FX CCD camera (Roper Scientific). Phase contrast and
fluorescence images were taken every 3 min for 20 frames (1 h)
with a 406 objective and a gfp filter. The Metamorph 6.1r6
(Universal Imaging) program was used for image processing.
SUPPORTING INFORMATION
Figure S1 Analysis of the level of synchrony in cell cultures. C9
cells were treated as described to induce the arrest of the cell cycle
at the G0/G1-S transition. After the release from the arrest, cells
were grown and analyzed by flow cytometry at different time-
points after DNA staining with propidium iodide. The panels
illustrate the cell cycle profiles of representative experiments for
control, arrested and 2-h and 4-h after the release from the arrest.
The graph summarizes the analysis of cell distribution during the
cell cycle of four independent synchronization experiments. Open
squares, control non-arrested cells; closed circles, arrested cells and
closed triangles cells at 4 h after release from the arrest. The results
shown are the means6S.E.M. * and {, P,0.01 when compared
with control and arrested cells, respectively.
Found at: doi:10.1371/journal.pone.0000107.s001 (0.17 MB TIF)
Figure S2 Accumulation of mitochondrial proteins during the
cell cycle. Determination of the expression level of mitochondrial
proteins was carried out by flow cytometry after the staining of the
cells with specific antibodies against b-F1-ATPase, Hsp60, COXI
and COXIV. Irrelevant isotype-specific IgGs and antibodies
against the T-cell receptor complex (TCRVb 8) were used as
controls. The histograms in (a) show the overlay of the
fluorescence intensity of each of the primary antibodies used (in
blue) with the signal provided by the secondary antibody (in red)
for the entire cell population analyzed. The histograms in (b) show
the fluorescence intensity of the cells in G0/G1 (in red), S (in blue)
and G2/M (in green) phases of the cell cycle. The mean
fluorescence intensity for each cellular subpopulation is shown.
Representative histograms are shown for each of the conditions
tested. The results illustrate the lack of overlapping of the
fluorescent signal of the mitochondrial markers with that of the
secondary antibody or of the two controls (IgGs and TCRVb 8).
Found at: doi:10.1371/journal.pone.0000107.s002 (0.17 MB TIF)
Figure S3 Changes in cellular morphology and on the mitochon-
drial network during mitosis. Different time-frames of phase contrast
(left panel) and fluorescence (right panel) images taken from the
supporting video 1 illustrate the changes in cellular morphology and
of the mitochondrial network during mitosis, respectively. a,
interphase; b, prophase; c, prometaphase; d, metaphase; e, anaphase
and f, telophase. Phase contrast images allowed the visualization of
filopodia (b,c) and chromosomes (d,e,f).
Found at: doi:10.1371/journal.pone.0000107.s003 (0.65 MB TIF)
Video S1 Changes in cellular morphology and on the mito-
chondrial network during mitosis. Phase contrast (left panel) and
fluorescence (right panel) images from mitochondria-tagged gfp
C9 cells were obtained every 3 min. The cellular shape changes
dramatically during mitosis. In prophase/prometaphase, the
plasma membrane promotes the protrusion of thin filopodia for
cellular detachment triggering the clustering of mitochondria
towards the cell nuclei. Fission of thread-like mitochondria is
observed as a very early event of the initiation of mitosis (,12–
15 min) and is clearly finalized in metaphase. Some images
representing individual frames of the movie are shown in Fig. S3.
Found at: doi:10.1371/journal.pone.0000107.s004 (5.04 MB AVI)
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